Zuckerman Investment Group LLC Has $22.40 Million Holdings in Kenvue Inc. $KVUE

Zuckerman Investment Group LLC raised its holdings in Kenvue Inc. (NYSE:KVUE) by 44.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,380,266 shares of the company’s stock after acquiring an additional 425,305 shares during the period. Kenvue comprises 2.1% of Zuckerman Investment Group LLC’s holdings, making the stock its 18th biggest holding. Zuckerman Investment Group LLC owned approximately 0.07% of Kenvue worth $22,402,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Quinn Opportunity Partners LLC bought a new position in shares of Kenvue in the third quarter worth about $1,923,000. Banco BTG Pactual S.A. bought a new stake in shares of Kenvue during the 3rd quarter valued at approximately $162,000. Marshall Wace LLP increased its position in Kenvue by 1,268.0% during the 3rd quarter. Marshall Wace LLP now owns 882,603 shares of the company’s stock worth $14,325,000 after purchasing an additional 818,083 shares in the last quarter. Landscape Capital Management L.L.C. bought a new position in Kenvue in the 3rd quarter valued at approximately $1,972,000. Finally, Huber Capital Management LLC lifted its stake in Kenvue by 31.4% in the 3rd quarter. Huber Capital Management LLC now owns 243,300 shares of the company’s stock valued at $3,949,000 after purchasing an additional 58,200 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Kenvue Trading Up 0.7%

Shares of NYSE KVUE opened at $17.51 on Friday. The firm has a 50 day moving average price of $17.89 and a two-hundred day moving average price of $17.32. The stock has a market cap of $33.55 billion, a P/E ratio of 22.73, a price-to-earnings-growth ratio of 3.95 and a beta of 0.51. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.96.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company had revenue of $3.78 billion for the quarter, compared to analyst estimates of $3.68 billion. During the same quarter in the previous year, the business earned $0.26 earnings per share. Kenvue’s revenue was up 3.2% compared to the same quarter last year. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is 107.79%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on KVUE. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the stock from $23.00 to $18.00 in a research note on Friday, January 30th. Argus upgraded Kenvue to a “hold” rating in a research note on Friday, March 6th. Barclays raised their price objective on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Friday, March 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Finally, Citigroup increased their target price on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.